表皮卵巢癌复发和根据治疗模式转变的生存率的变化
Jeongyun Kim1, Dong Hoon Suh1,2, Kidong Kim1,2
1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea.
The journal of obstetrics and gynaecology research
|February 13, 2026
概括
这项研究表明,虽然上皮卵巢癌 (EOC) 的无进展生存率 (PFS) 没有变化,但由于手术技术和向治疗的进步,五年总生存率 (OS) 显著提高.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术瘤学手术瘤学
- 医学瘤学 医学瘤学
背景情况:
- 不断发展的外科和全身治疗模式影响了上皮卵巢癌 (EOC) 的结果.
- 了解长期的瘤结果对于患者管理至关重要.
研究的目的:
- 为了评估上皮卵巢癌 (EOC) 患者的瘤结果.
- 评估不断发展的手术和全身治疗对生存的影响.
主要方法:
- 763名EOC患者的回顾性队列研究 (2003-2020年).
- 根据诊断期分组的患者,以反映治疗变化.
- 使用Kaplan-Meier和Cox回归分析的整体存活率 (OS) 和无进展存活率 (PFS).
主要成果:
- 随着时间的推移,完整的细胞减少率有所增加,特别是在初级脱皮手术 (PDS) 中.
- 间隔除手术 (IDS) 的使用增加,但IDS后的残留疾病 (<1厘米) 与较差的结果相关.
- 尽管PFS没有变化,但在最近一段时间内,晚期EOC患者的5年OS显著改善 (64.0%至82.5%).
结论:
- 在EOC治疗中,越来越多地实现了完整的细胞减少,特别是通过PDS.
- 虽然IDS的使用增加了,但残留疾病仍然是一个负面的预后因素.
- 针对性治疗和外科手术策略的进步使得晚期EOC患者的长期存活率有所改善.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.1K
07:46In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
Published on: August 17, 2010
34.6K
相关概念视频
Cancer Survival Analysis
774
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
774
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Survival Curves
745
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
745
Survival Tree
437
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
437
Introduction To Survival Analysis
840
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
840
Comparing the Survival Analysis of Two or More Groups
618
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
618
